Sana Biotechnology, Inc. financial data

Symbol
SANA on Nasdaq
Location
188 East Blaine Street, Suite 400, Seattle, WA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 351 % -25.1%
Debt-to-equity 124 % +42.4%
Return On Equity -121 % -27.7%
Return On Assets -53.8 % -6.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 266M shares +19.3%
Common Stock, Shares, Outstanding 262M shares +17.6%
Entity Public Float 596M USD -0.73%
Common Stock, Value, Issued 26K USD +18.2%
Weighted Average Number of Shares Outstanding, Basic 260M shares +10.7%
Weighted Average Number of Shares Outstanding, Diluted 260M shares +10.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 144M USD -38.3%
General and Administrative Expense 49.4M USD -26.9%
Operating Income (Loss) -240M USD +23.2%
Net Income (Loss) Attributable to Parent -234M USD +23.3%
Earnings Per Share, Basic 0 USD/shares +30.2%
Earnings Per Share, Diluted 0 USD/shares +30.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 103M USD -18.6%
Marketable Securities, Current 49.7M USD -31%
Assets, Current 162M USD -23%
Property, Plant and Equipment, Net 29.9M USD -63.9%
Operating Lease, Right-of-Use Asset 40.7M USD -33.3%
Intangible Assets, Net (Excluding Goodwill) 59.2M USD 0%
Goodwill 141M USD 0%
Other Assets, Noncurrent 3.22M USD -42.1%
Assets 435M USD -22.2%
Accounts Payable, Current 1.86M USD -37.9%
Employee-related Liabilities, Current 11.3M USD -37.4%
Liabilities, Current 35.5M USD -24.4%
Operating Lease, Liability, Noncurrent 67.9M USD -20.6%
Other Liabilities, Noncurrent 7.88M USD +5.63%
Liabilities 240M USD -10%
Accumulated Other Comprehensive Income (Loss), Net of Tax 21K USD -61.1%
Retained Earnings (Accumulated Deficit) -1.79B USD -15.1%
Stockholders' Equity Attributable to Parent 195M USD -33.2%
Liabilities and Equity 435M USD -22.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.7M USD +25.9%
Net Cash Provided by (Used in) Financing Activities 982K USD -99.5%
Net Cash Provided by (Used in) Investing Activities 16.6M USD
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 262M shares +17.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.1M USD -171%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 108M USD -17.8%
Deferred Tax Assets, Valuation Allowance 451M USD +11.9%
Deferred Tax Assets, Gross 465M USD +9.45%
Operating Lease, Liability 82.2M USD -14.4%
Depreciation 15.4M USD -33.2%
Payments to Acquire Property, Plant, and Equipment 136K USD -99.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -234M USD +23.3%
Lessee, Operating Lease, Liability, to be Paid 125M USD -29.3%
Property, Plant and Equipment, Gross 83.8M USD -38.3%
Operating Lease, Liability, Current 14.4M USD +35.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.4M USD -13.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.5M USD +3.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure -8.77%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.6M USD -47%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14.7M USD -26.1%
Deferred Tax Assets, Operating Loss Carryforwards 228M USD +18.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.1M USD -7.59%
Additional Paid in Capital 1.99B USD +7.43%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 14.7M USD -34.8%
Share-based Payment Arrangement, Expense 25.6M USD -34.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%